Telfast



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 27.3%
Product Used For Unknown Indication 19.7%
Eczema 9.1%
Urticaria 6.1%
Asthma 4.5%
Neuropathic Pain 4.5%
Seasonal Allergy 4.5%
Gastrooesophageal Reflux Disease 3.0%
Mineral Supplementation 3.0%
Rhinitis 3.0%
Alpha-1 Anti-trypsin Deficiency 1.5%
Angina Pectoris 1.5%
Attention Deficit/hyperactivity Disorder 1.5%
Blood Pressure 1.5%
Depression 1.5%
Gout 1.5%
Hypersensitivity 1.5%
Hypertension 1.5%
Nasal Congestion 1.5%
Palpitations 1.5%
Spleen Disorder 10.3%
Toxic Skin Eruption 10.3%
Hallucination 6.9%
Metabolic Disorder 6.9%
Tremor 6.9%
Unevaluable Event 6.9%
Vestibular Disorder 6.9%
Circulatory Collapse 3.4%
Convulsion 3.4%
Dacryostenosis Acquired 3.4%
Electrocardiogram Qt Prolonged 3.4%
Face Oedema 3.4%
Foetal Exposure During Pregnancy 3.4%
Haemorrhage 3.4%
Hepatotoxicity 3.4%
Local Swelling 3.4%
Myocardial Infarction 3.4%
Palpitations 3.4%
Paraesthesia 3.4%
Pregnancy 3.4%
Secondary
Epilepsy 10.1%
Supraventricular Tachycardia 9.3%
Rash 8.3%
Dermatitis 8.0%
Chronic Obstructive Pulmonary Disease 7.8%
Product Used For Unknown Indication 7.8%
Tachycardia Paroxysmal 6.2%
Drug Use For Unknown Indication 5.7%
Pruritus 4.7%
Prophylaxis 4.1%
Pain 3.4%
Thrombosis Prophylaxis 3.4%
Grand Mal Convulsion 3.1%
Rheumatoid Arthritis 3.1%
Sleep Disorder 2.8%
Conjunctivitis 2.6%
Essential Hypertension 2.6%
Nausea 2.6%
Vomiting 2.6%
Asthma 2.1%
Toxic Epidermal Necrolysis 23.9%
Abortion Spontaneous 10.9%
Paraesthesia 8.7%
Rash 6.5%
Rash Maculo-papular 6.5%
Exposure During Pregnancy 4.3%
Hallucination 4.3%
Rash Macular 4.3%
Spleen Disorder 4.3%
Toxic Skin Eruption 4.3%
Arthralgia 2.2%
Cytolytic Hepatitis 2.2%
Drug Exposure During Pregnancy 2.2%
Drug Interaction 2.2%
Eosinophilia 2.2%
Hepatitis 2.2%
Intraocular Pressure Increased 2.2%
Myocardial Infarction 2.2%
Pruritus 2.2%
Suicide Attempt 2.2%
Concomitant
Drug Use For Unknown Indication 28.6%
Product Used For Unknown Indication 11.9%
Prophylaxis 6.7%
Depression 6.5%
Hypertension 5.8%
Asthma 4.7%
Urticaria 3.9%
Premedication 3.2%
Rheumatoid Arthritis 3.2%
Hypersensitivity 3.0%
Myocardial Ischaemia 2.8%
Seasonal Allergy 2.8%
Arthralgia 2.6%
Insomnia 2.3%
Abdominal Pain Upper 2.1%
Colorectal Cancer 2.1%
Hepatitis C 2.1%
Anxiety 1.9%
Eczema 1.9%
Mucopolysaccharidosis I 1.9%
Urticaria 15.8%
Somnolence 6.6%
Urinary Tract Infection 6.6%
Toxic Skin Eruption 5.3%
Vision Blurred 5.3%
Vomiting 5.3%
Weight Decreased 5.3%
Wheezing 5.3%
Withdrawal Syndrome 5.3%
Extrasystoles 3.9%
General Physical Health Deterioration 3.9%
Interstitial Lung Disease 3.9%
Paraesthesia 3.9%
Rash 3.9%
Sudden Death 3.9%
Tachycardia 3.9%
Ulnar Nerve Palsy 3.9%
Abortion Spontaneous 2.6%
Anaphylactic Reaction 2.6%
Arteriovenous Fistula Site Complication 2.6%
Interacting
Mineral Supplementation 33.3%
Prophylaxis 16.7%
Pruritus 16.7%
Blood Pressure 8.3%
Blood Pressure Management 8.3%
Pruritus Generalised 8.3%
Alpha-1 Anti-trypsin Deficiency 4.2%
Attention Deficit/hyperactivity Disorder 4.2%
Paraesthesia 80.0%
Trismus 20.0%